ArticleCatheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions2026
Elevated Hemoglobin Levels and Risk of ST-Segment Elevation Myocardial Infarction in High-Altitude Acute Coronary Syndrome: A Retrospective Analysis.
Article in Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Elevated Hemoglobin Levels and Risk of ST-Segment Elevation Myocardial Infarction in High-Altitude Acute Coronary Syndrome: A Retrospective Analysis.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2026Article
- Development and external validation of an admission-based model for 180-day mortality in diabetic acute myocardial infarction.Frontiers in endocrinology · 2026Article
- High-altitude exposure and ischemic stroke: pathophysiological mechanisms and current perspectives.Frontiers in neurologyReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundHigh-altitude populations typically exhibit elevated hemoglobin (Hb) levels due to chronic hypoxic exposure; however, the impact of this elevation on the risk of ST-segment elevation myocardial infarction (STEMI) remains unclear. Existing evidence is primarily derived from low-altitude populations and cannot be directly extrapolated to high-altitude settings.
aimsThis study aims to systematically evaluate the effect of elevated hemoglobin levels in high-altitude environments on the risk of ST-segment elevation myocardial infarction (STEMI) and to identify the altitude-specific inflection point at which hemoglobin becomes a significant risk factor.
methodsThis study involved 1209 patients diagnosed with acute coronary syndrome (ACS). The patients were classified into four groups according to their Hb levels: < 120, 120-160, 160-200, and ≥ 200 g/L. Initially, logistic regression and restricted cubic splines (RCS) were employed to evaluate the relationship between Hb levels and the risk of STEMI. Subsequently, survival analysis was conducted to assess 28-day survival rates. RCS curves were then compared with data from low-altitude populations. Finally, subgroup analyses were performed to further validate the robustness of the findings.
resultsThe study population comprised 80.9% males (mean age 58.3 ± 12.5 years) and 19.1% females (mean age 66.0 ± 11.9 years). Elevated Hb levels (≥ 160 g/L) were significantly associated with an increased risk of STEMI. RCS analysis revealed a nonlinear relationship between Hb levels and STEMI risk (nonlinearity p < 0.05). After adjusting for multiple variables, the odds ratios (OR) for STEMI in patients with Hb levels of 160-200 and ≥ 200 g/L were 1.9 (95% CI: 1.1-3.1, p = 0.019) and 3.6 (95% CI: 1.8-7.3, p < 0.001), respectively.
conclusionsIn high-altitude ACS patients, Hb levels ≥ 160 g/L significantly increase the risk of STEMI, underscoring the importance of Hb monitoring in this population.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.